Dan Shelly

Company: PolTREG

Job title: Chief Business Development Officer

Seminars:

Antigen-Specific Tregulatory Cells and the Development of a T1D Vaccine: Clinically Derived Antigen-Specific Peptide-Based Modalities 1:30 pm

• Review of clinical progress with Tregualtory cell therapies • Development of a powerful Peptidomic and cell based assay platform for validating disease specific peptides from clinical samples • Development of antigen-specific Tregulatory cell therapy and mRNA encoded peptide vaccine for Type 1 diabetes and other autoimmune diseasesRead more

day: Conference Day One